Pixyl.Neuro.BV is a volumetry tool measuring brain atrophy. It integrates into the routine workflow to quantify the volume of different tissues and structures in the brain, as well as any changes from the previous visit if there is one (longitudinal analysis). It also compares patient values to a normative population. The software outputs a quantitative report on tissue and structure volume, and changes relative to the prior visit. It also provides graphs to visualize the evolution of certain volumes with respect to normative values.
Information source: Vendor
Last updated: Nov. 23, 2023

General Information

Product name Pixyl.Neuro.BV
Company Pixyl
Subspeciality Neuro
Modality MR
Disease targeted Neurodegenerative diseases, dementia, Alzheimer’s disease, Multiple Sclerosis, Parkinson’s disease
Key-features Brain volume quantification, brain segmentation, comparison with normative values, longitudinal analysis
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population patients with known or suspected neurodegenerative disease
Input MR sequence, 3D T1-weighted image
Input format DICOM
Output structured quantitative report, table of quantified values, comparison with normative values, graphs of volume evolution with respect to normative values, brain MRI representative screenshots, longitudinal analysis
Output format PDF report, DICOM report
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes


Certified, Class IIa , MDR
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE) Pixyl.Neuro is intended for the automatic labelling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MRI images. Volumetric measurements may be compared to reference percentile data.


Market presence
On market since 10-2019
Distribution channels Incepto, GE, Siemens, Blackford
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing model Subscription
Based on Number of installations, Number of analyses


Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers